GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jinyu Bio-Technology Co Ltd (SHSE:600201) » Definitions » 3-Year ROIIC %

Jinyu Bio-Technology Co (SHSE:600201) 3-Year ROIIC % : -11.53% (As of Dec. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Jinyu Bio-Technology Co 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Jinyu Bio-Technology Co's 3-Year ROIIC % for the quarter that ended in Dec. 2023 was -11.53%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Jinyu Bio-Technology Co's 3-Year ROIIC % or its related term are showing as below:

SHSE:600201's 3-Year ROIIC % is ranked better than
51.34% of 1416 companies
in the Biotechnology industry
Industry Median: -13.43 vs SHSE:600201: -11.53

Jinyu Bio-Technology Co 3-Year ROIIC % Historical Data

The historical data trend for Jinyu Bio-Technology Co's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jinyu Bio-Technology Co 3-Year ROIIC % Chart

Jinyu Bio-Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -20.97 -54.75 -24.31 -0.21 -11.53

Jinyu Bio-Technology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -11.53 -

Competitive Comparison of Jinyu Bio-Technology Co's 3-Year ROIIC %

For the Biotechnology subindustry, Jinyu Bio-Technology Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jinyu Bio-Technology Co's 3-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jinyu Bio-Technology Co's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Jinyu Bio-Technology Co's 3-Year ROIIC % falls into.



Jinyu Bio-Technology Co 3-Year ROIIC % Calculation

Jinyu Bio-Technology Co's 3-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( 284.9786426 (Dec. 2023) - 390.217023 (Dec. 2020) )/( 4445.467 (Dec. 2023) - 3532.868 (Dec. 2020) )
=-105.2383804/912.599
=-11.53%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Jinyu Bio-Technology Co  (SHSE:600201) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Jinyu Bio-Technology Co 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Jinyu Bio-Technology Co's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Jinyu Bio-Technology Co (SHSE:600201) Business Description

Traded in Other Exchanges
N/A
Address
No.1, Jinyu Street, Shaeryu Industrial Park, Economic and Technological Development Zone, Inner Mongolia Autonomous Region, Hohhot, CHN, 010030
Jinyu Bio-Technology Co Ltd is engaged in the development and sales of veterinary biological products. Its products are used for pigs, poultry, pets, and ruminants.
Executives
Zhang Chong Yu Director
Zhang Jing Directors, senior managers
Yang Zhao senior management
Li Rong senior management
Zhang Zhan Fu Supervisors
Wei Xue Feng Director
Wang Yong Sheng Directors, senior managers
Yin Song Tao Directors, senior managers
Liu Guo Ying Supervisors
Zhang Hong Mei senior management
Wen Li Min Director
Xu Xian Ming Director
Xu Shi Jun Director
Wang Xiu Hua Director
Li Shu Jian senior management

Jinyu Bio-Technology Co (SHSE:600201) Headlines

No Headlines